Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02091128
Other study ID # METC 13-4-127
Secondary ID
Status Completed
Phase N/A
First received March 13, 2014
Last updated September 12, 2016
Start date March 2014
Est. completion date September 2016

Study information

Verified date September 2016
Source Maastricht University Medical Center
Contact n/a
Is FDA regulated No
Health authority Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
Study type Observational

Clinical Trial Summary

With this study, in which the incidence of pregnancy in classic galactosemia patients is studied, we aim to provide new insights to improve counselling. Our hypothesis is that the chance that a galactosemic woman with POI becomes pregnant is higher than the 5-10% that has been reported for women with POI due to other causes. Chance of spontaneous pregnancy will be evaluated through semi standardized interview in women with classic galactosemia aged 18 years or older. During the interview, questions will be asked regarding fertility and pregnancy.


Recruitment information / eligibility

Status Completed
Enrollment 85
Est. completion date September 2016
Est. primary completion date September 2016
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Classic galactosemia diagnosed by GALT enzyme activity assay or GALT-gene mutation analysis

- Eighteen years of age or older

- Diagnosed with POI defined as symptoms of hypergonadotrophic hypogonadism measured by serum concentrations of FSH and estradiol

- Capable of giving informed consent

Exclusion Criteria:

- Any known congenital or acquired disease or disorder negatively affecting pubertal development and/or fertility.

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional


Locations

Country Name City State
Netherlands Maastricht University Medical Center Maastricht

Sponsors (1)

Lead Sponsor Collaborator
Maastricht University Medical Center

Country where clinical trial is conducted

Netherlands, 

References & Publications (1)

Gubbels CS, Land JA, Rubio-Gozalbo ME. Fertility and impact of pregnancies on the mother and child in classic galactosemia. Obstet Gynecol Surv. 2008 May;63(5):334-43. doi: 10.1097/OGX.0b013e31816ff6c5. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Pregnancy incidence despite POI diagnosis Will be assessed during semi-standardized interview day 1 No
Secondary Whether women have tried to conceive Will be assessed during semi-standardized interview day 1 No
Secondary Time to pregnancy (in case a participant has been pregnant) Will be assessed during semi-standardized interview day 1 No
Secondary Menstrual history Will be assessed during semi-standardized interview day 1 No
Secondary Hormonal replacement therapy usage Will be assessed during semi-standardized interview day 1 No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02871986 - Pubertal Induction in Individuals With Hypogonadism N/A
Recruiting NCT02322060 - In Vitro Activation of Dormant Follicles for Patients With Primary Ovarian Insufficiency
Recruiting NCT06167135 - Polycystic Ovary Syndrome, Mitochondrial Dysfunction, Obesity, Insulin Resistance Infertility (POMODORI) Cohort
Active, not recruiting NCT04675970 - Long Term Follow up Patients With Premature Ovarian Failure ex Vivo Gene Therapy
Completed NCT04943354 - Associations of Combinations of Single-nucleotide Polymorphisms in Women With Premature Ovarian Failure N/A
Recruiting NCT03518918 - Establishing the Diagnosis Standard and Analysis the Risk Factors of POI in Chinese Women
Recruiting NCT05021094 - Clinical Observation on Kuntai Capsule in Treating Early-onset Ovarian Hypofunction Phase 4
Active, not recruiting NCT02795000 - Development a Predictive Nomogram for Primary Ovarian Insufficiency
Suspended NCT03021915 - Single Center, Prospective Controlled Pilot Study of the OvaPrime Procedure N/A
Completed NCT01436513 - A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions. Phase 1
Recruiting NCT06117982 - The Impact of Granulocyte Colony Stimulating Factor on Premature Ovarian Insufficiency Phase 2
Recruiting NCT02068976 - Observational Epidemiologic Study in Women With Premature Ovarian Failure (POF)
Completed NCT01973075 - Genetic Etiology in Premature Ovarian Insufficiency N/A
Completed NCT03568708 - Primary Ovarian Insufficiency: Phenotype and Optimal Treatment Phase 3
Not yet recruiting NCT02757469 - Oral Contraceptives as Infertility Treatments for Premature Ovarian Failure N/A
Terminated NCT00650754 - Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility Phase 2/Phase 3
Recruiting NCT03496636 - Autologous Ovarian Tissue Transplantation N/A
Active, not recruiting NCT05737329 - Efficacy, Safety, and Tolerability of Higher Doses Estrogen Therapy in Women With Premature Ovarian Insufficiency Phase 1/Phase 2
Withdrawn NCT02922348 - Hormone Replacement for Premature Ovarian Insufficiency Phase 3
Completed NCT05310617 - Parental Project and Premature Ovarian Insufficiency